Update: Pyxis Oncology Shares Fall After Pricing Public Offering of Common Stock, Warrants

02:46 PM EDT, 09/30/2026 (MT Newswires) -- (Updates with the latest stock movement in the headline and the first paragraph.) Pyxis Oncology (PYXS) shares were down more than 23% in Wednesday afternoon trading after the company said it has priced a public offering of common stock and warrants for expected gross proceeds of about $110 million. The offering includes 36.05 million common shares, or pre-funded warrants in lieu of 1.88 million shares for certain investors, and accompanying warrants to purchase 49.31 million common shares at $3.50 each, Pyxis Oncology said. The combined offering price is $2.90 per share and warrant, or $2.899 per pre-funded warrant and warrant, the company said. Net proceeds will be used to advance its lead clinical program, working capital, and general corporate purposes, Pyxis Oncology said. The offering is expected to close around Thursday. Price: 2.23, Change: -0.68, Percent Change: -23.28